Literature DB >> 11735648

Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans.

Z Katsarava1, H C Diener, V Limmroth.   

Abstract

Medication overuse headache (MOH, formerly known as drug-induced headache) is a well known disorder following the frequent use of analgesics or any other antiheadache drug including serotonin 5-HT(1B/D) agonists (triptans). Recent studies suggest clinical features of MOH depend on the substance class that has been overused. The delay between the frequent intake of any antiheadache drug and daily headache is shortest for triptans (mean 1.7 years), longer for ergot alkaloids (mean 2.7 years) and longest for analgesics (mean 4.9 years). Treatment includes withdrawal followed by structured acute therapy and initiation of specific prophylactic treatment for the underlying primary headache. The relapse rate within 6 months after successful withdrawal is about 30% and increases steadily up to 50% after 5 years.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735648     DOI: 10.2165/00002018-200124120-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  37 in total

1.  Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial.

Authors:  M van Dusseldorp; M B Katan
Journal:  BMJ       Date:  1990-06-16

2.  Easy therapeutical management of sumatriptan-induced daily headache.

Authors:  H Göbel; H Stolze; A Heinze; M Dworschak
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

3.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

4.  Sumatriptan.

Authors:  H Kaube; A May; V Pfaffenrath
Journal:  BMJ       Date:  1994-06-11

5.  Butorphanol (Stadol): a study in problems of current drug information and control.

Authors:  M A Fisher; S Glass
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

6.  [Prophylaxis and treatment of drug-induced persistent headache. Therapy recommendation of the German Society for Migraine and Headache].

Authors:  G Haag; H Baar; K H Grotemeyer; V Pfaffenrath; M J Ribbat; H C Diener
Journal:  Schmerz       Date:  1999-02-18       Impact factor: 1.107

7.  Analgesic rebound headache in clinical practice: data from a physician survey.

Authors:  A Rapoport; P Stang; D L Gutterman; R Cady; H Markley; R Weeks; J Saiers; A W Fox
Journal:  Headache       Date:  1996-01       Impact factor: 5.887

8.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

9.  Drug abuse in chronic headache: a clinico-epidemiologic study.

Authors:  F Granella; S Farina; G Malferrari; G C Manzoni
Journal:  Cephalalgia       Date:  1987-03       Impact factor: 6.292

10.  Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches.

Authors:  C Baumgartner; P Wessely; C Bingöl; J Maly; F Holzner
Journal:  Headache       Date:  1989-09       Impact factor: 5.887

View more
  8 in total

Review 1.  Update on medication-overuse headache.

Authors:  Milena De Felice; Michael H Ossipov; Frank Porreca
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 2.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Rebound-withdrawal headache (medication overuse headache).

Authors:  James R Couch
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

Review 4.  Oral triptans in the preventive management of cluster headache.

Authors:  Lutz Pageler; Volker Limmroth
Journal:  Curr Pain Headache Rep       Date:  2012-04

Review 5.  Drug overuse and rebound headache.

Authors:  Stephen D Silberstein; Dongmei Liu
Journal:  Curr Pain Headache Rep       Date:  2002-06

6.  Drug dependence associated with triptans and ergot derivatives: a case/non-case study.

Authors:  Frédérique Beau-Salinas; Annie Pierre Jonville-Béra; Haware Cissoko; Lamiae Bensouda-Grimaldi; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2009-12-19       Impact factor: 2.953

7.  Prevalence of migraine and tension-type headache among adults in Jordan.

Authors:  Karem H Alzoubi; Nizar Mhaidat; Sayer Al Azzam; Yousef Khader; Saad Salem; Hanin Issaifan; Rania Haddadin
Journal:  J Headache Pain       Date:  2009-04-23       Impact factor: 7.277

Review 8.  The long-term prognosis of tension-type headache.

Authors:  James R Couch
Journal:  Curr Pain Headache Rep       Date:  2005-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.